Cathelicidin Peptide LL-37 Modulates TREM-1 Expression and Inflammatory Responses to Microbial Compounds
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LL-37 has a broad-spectrum of bactericidal activity, may play a role in cystic fibrosis remediation, and has been found to inhibit HIV-1 infection in vitro (37, 220, 221).”
From On the Role of NMR Spectroscopy for Characterization of Antimicrobial Peptides (2013) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 1×
“These include chemokine induction [13, 16, 17], stimulation of mast cell antimicrobial and pro-inflammatory functions [18, 19], stimulation of dendritic cell activation in synergy with oligonucleotides [20, 21], modulation of neutrophil survival [22–24], and promotion of cytokine production in combination with IL-1β […”
BackgroundBouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 4×
“TREM1 ligation with an agonist antibody induces cytokine production in monocytes and promotes antimicrobial functions of neutrophils [35, 43].”
BackgroundInfluentialLL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988 · cited 2×
“At physiological concentrations of divalent cations and serum, it is weakly or non-antimicrobial [8], but exhibits a broad range of immunomodulatory activities on the immune system of the host [1–3].”
BackgroundSørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., & Borregaard, N. (2001) · Blood · doi:10.1182/blood.v97.12.3951 · Cited by 894 · cited 1×
“It is produced from a precursor protein hCAP-18 by proteolysis [4, 5 ] and is found at mucosal surfaces and in various tissues at estimated concentrations of 2–5 μg/ml and at higher levels under inflammatory conditions [6, 7]. At physiological concentrations of divalent cations and serum, it is weakly or non-antimicro…”
BackgroundSelf-citationTREM and TREM-like receptors in inflammation and disease
Ford, J. W., & McVicar, D. W. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.009 · Cited by 434
An anti-infective peptide that selectively modulates the innate immune response
Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1288 · Cited by 403 · cited 1×
“Indeed, short synthetic peptides with potent anti-infective activities have been designed to share the anti-inflammatory and immune-stimulating properties of natural cathelicidins ([12, 33, 34] and unpublished data) and are in phase I/II clinical trials (www.”
BackgroundSelf-citation
Research works printed but not linked: 65
- Nijnik, A., and R.E.W. Hancock. 2009. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Current Opinion in Hematology 16: 41–47. · DOI · Paper page
- Larrick, J.W., J. Lee, S. Ma, X. Li, U. Francke, S.C. Wright, and R.F. Balint. 1996. Structural, functional analysis and localization of the human CAP18 gene. FEBS Letters 398: 74–80. · DOI · Paper page
- Bals, R., D.J. Weiner, R.L. Meegalla, and J.M. Wilson. 1999. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. Journal of Clinical Investigation 103: 1113–1117. · DOI · Paper page
- Schaller-Bals, S., A. Schulze, and R. Bals. 2002. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. American Journal of Respiratory and Critical Care Medicine 165: 992–995. · DOI · Paper page
- Bowdish, D.M., D.J. Davidson, Y.E. Lau, K. Lee, M.G. Scott, and R.E. Hancock. 2005. Impact of LL-37 on anti-infective immunity. Journal of Leukocyte Biology 77: 451–459. · DOI · Paper page
- Mookherjee, N., K.L. Brown, D.M. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F.M. Roche, R. Mu, G.H. Doho, J. Pistolic, J.P. Powers, J. Bryan, F.S. Brinkman, and R.E. Hancock. 2006. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. Journal of Immunology 176: 2455–2464. · DOI · Paper page
- Kandler, K., R. Shaykhiev, P. Kleemann, F. Klescz, M. Lohoff, C. Vogelmeier, and R. Bals. 2006. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. International Immunology 18: 1729–1736. · DOI
- Molhoek, E.M., A.L. den Hertog, A.M. de Vries, K. Nazmi, E.C. Veerman, F.C. Hartgers, M. Yazdanbakhsh, F.J. Bikker, and D. van der Kleij. 2009. Structure–function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biological Chemistry 390: 295–303. · DOI
- Nell, M.J., G.S. Tjabringa, A.R. Wafelman, R. Verrijk, P.S. Hiemstra, J.W. Drijfhout, and J.J. Grote. 2006. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27: 649–660. · DOI · Paper page
- Scott, M.G., D.J. Davidson, M.R. Gold, D. Bowdish, and R.E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. Journal of Immunology 169: 3883–3891. · DOI · Paper page
- Pinheiro da Silva, F., R.L. Gallo, and V. Nizet. 2009. Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling. Immunology and Cell Biology 87(6): 496–500. · DOI
- Di Nardo, A., M.H. Braff, K.R. Taylor, C. Na, R.D. Granstein, J.E. McInturff, S. Krutzik, R.L. Modlin, and R.L. Gallo. 2007. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. Journal of Immunology 178: 1829–1834. · DOI · Paper page
- Tjabringa, G.S., J. Aarbiou, D.K. Ninaber, J.W. Drijfhout, O.E. Sorensen, N. Borregaard, K.F. Rabe, and P.S. Hiemstra. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. Journal of Immunology 171: 6690–6696. · DOI · Paper page
- Elssner, A., M. Duncan, M. Gavrilin, and M.D. Wewers. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. Journal of Immunology 172: 4987–4994. · DOI · Paper page
- Niyonsaba, F., A. Someya, M. Hirata, H. Ogawa, and I. Nagaoka. 2001. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. European Journal of Immunology 31: 1066–1075. · DOI · Paper page
- Schiemann, F., E. Brandt, R. Gross, B. Lindner, J. Mittelstadt, C.P. Sommerhoff, J. Schulmistrat, and F. Petersen. 2009. The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: Counter-regulation by CXCL4. Journal of Immunology 183: 2223–2231. · DOI
- Ganguly, D., G. Chamilos, R. Lande, J. Gregorio, S. Meller, V. Facchinetti, B. Homey, F.J. Barrat, T. Zal, and M. Gilliet. 2009. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. The Journal of Experimental Medicine 206: 1983–1994. · DOI · Paper page
- Zhang, Z., G. Cherryholmes, and J.E. Shively. 2008. Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. Journal of Leukocyte Biology 84: 780–788. · DOI
- Barlow, P.G., Y. Li, T.S. Wilkinson, D.M. Bowdish, Y.E. Lau, C. Cosseau, C. Haslett, A.J. Simpson, R.E. Hancock, and D.J. Davidson. 2006. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. Journal of Leukocyte Biology 80: 509–520. · DOI · Paper page
- Nagaoka, I., H. Tamura, and M. Hirata. 2006. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. Journal of Immunology 176: 3044–3052. · DOI · Paper page
- Yu, J., N. Mookherjee, K. Wee, D.M. Bowdish, J. Pistolic, Y. Li, L. Rehaume, and R.E. Hancock. 2007. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. Journal of Immunology 179: 7684–7691. · DOI · Paper page
- Mookherjee, N., P. Hamill, J. Gardy, D. Blimkie, R. Falsafi, A. Chikatamarla, D.J. Arenillas, S. Doria, T.R. Kollmann, and R.E. Hancock. 2009. Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells. Molecular Biosystems 5: 483–496. · DOI
- An, L.L., Y.H. Yang, X.T. Ma, Y.M. Lin, G. Li, Y.H. Song, and K.F. Wu. 2005. LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccine. Leukemia Research 29: 535–543. · DOI
- Kurosaka, K., Q. Chen, F. Yarovinsky, J.J. Oppenheim, and D. Yang. 2005. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. Journal of Immunology 174: 6257–6265. · DOI · Paper page
- Yamasaki, K., A. Di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R.A. Dorschner, C. Bonnart, P. Descargues, A. Hovnanian, V.B. Morhenn, and R.L. Gallo. 2007. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Natural Medicines 13: 975–980. · DOI · Paper page
- Hamill, P., K. Brown, H. Jenssen, and R.E. Hancock. 2008. Novel anti-infectives: Is host defence the answer? Current Opinion in Biotechnology 19: 628–636. · DOI
- Hancock, R.E., and H.G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology 24: 1551–1557. · DOI · Paper page
- Mookherjee, N., L.M. Rehaume, and R.E. Hancock. 2007. Cathelicidins and functional analogues as antisepsis molecules. Expert Opinion on Therapeutic Targets 11: 993–1004. · DOI
- Nijnik, A., L. Madera, S. Ma, M. Waldbrook, M.R. Elliott, D.M. Easton, M.L. Mayer, S.C. Mullaly, J. Kindrachuk, H. Jenssen, and R.E. Hancock. 2010. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. Journal of Immunology 184: 2539–2950. · DOI · Paper page
- Klesney-Tait, J., I.R. Turnbull, and M. Colonna. 2006. The TREM receptor family and signal integration. Nature Immunology 7: 1266–1273. · DOI · Paper page
- Chen, L.C., J.D. Laskin, M.K. Gordon, and D.L. Laskin. 2008. Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Experimental and Molecular Pathology 84: 145–155. · DOI
- Gibot, S., C. Buonsanti, F. Massin, M. Romano, M.N. Kolopp-Sarda, F. Benigni, G.C. Faure, M.C. Bene, P. Panina-Bordignon, N. Passini, and B. Levy. 2006. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infection and Immunity 74: 2823–2830. · DOI
- Haselmayer, P., L. Grosse-Hovest, P. von Landenberg, H. Schild, and M.P. Radsak. 2007. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 110: 1029–1035. · DOI · Paper page
- Wong-Baeza, I., N. Gonzalez-Roldan, E. Ferat-Osorio, N. Esquivel-Callejas, R. Aduna-Vicente, L. Arriaga-Pizano, H. Astudillo-de la Vega, M.A. Villasis-Keever, R. Torres-Gonzalez, I. Estrada-Garcia, C. Lopez-Macias, and A. Isibasi. 2006. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clinical and Experimental Immunology 145: 448–455. · DOI
- Mohamadzadeh, M., S.S. Coberley, G.G. Olinger, W.V. Kalina, G. Ruthel, C.L. Fuller, D.L. Swenson, W.D. Pratt, D.B. Kuhns, and A.L. Schmaljohn. 2006. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by Marburg and Ebola viruses. Journal of Virology 80: 7235–7244. · DOI
- Radsak, M.P., H.R. Salih, H.G. Rammensee, and H. Schild. 2004. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: Differential regulation of activation and survival. Journal of Immunology 172: 4956–4963. · DOI · Paper page
- Bouchon, A., F. Facchetti, M.A. Weigand, and M. Colonna. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103–1107. · DOI · Paper page
- Netea, M.G., T. Azam, G. Ferwerda, S.E. Girardin, S.H. Kim, and C.A. Dinarello. 2006. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors. Journal of Leukocyte Biology 80: 1454–1461. · DOI · Paper page
- Schenk, M., A. Bouchon, F. Seibold, and C. Mueller. 2007. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. Journal of Clinical Investigation 117: 3097–3106. · DOI · Paper page
- Gibot, S., F. Massin, C. Alauzet, M. Derive, C. Montemont, S. Collin, S. Fremont, and B. Levy. 2010. Effects of the TREM-1 pathway modulation during hemorrhagic shock in rats. Shock 32(6): 633–637. · DOI
- Lagler, H., O. Sharif, I. Haslinger, U. Matt, K. Stich, T. Furtner, B. Doninger, K. Schmid, R. Gattringer, A.F. de Vos, and S. Knapp. 2009. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. Journal of Immunology 183: 2027–2036. · DOI · Paper page
- Gibot, S., F. Massin, M. Marcou, V. Taylor, R. Stidwill, P. Wilson, M. Singer, and G. Bellingan. 2007. TREM-1 promotes survival during septic shock in mice. European Journal of Immunology 37: 456–466. · DOI
- Darveau, R.P., and R.E. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. Journal of Bacteriology 155: 831–838. · DOI · Paper page
- Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29: e45. · DOI · Paper page
- Knapp, S., S. Gibot, A. de Vos, H.H. Versteeg, M. Colonna, and T. van der Poll. 2004. Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. Journal of Immunology 173: 7131–7134. · DOI
- Gomez-Pina, V., A. Soares-Schanoski, A. Rodriguez-Rojas, C. Del Fresno, F. Garcia, M.T. Vallejo-Cremades, I. Fernandez-Ruiz, F. Arnalich, P. Fuentes-Prior, and E. Lopez-Collazo. 2007. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. Journal of Immunology 179: 4065–4073. · DOI · Paper page
- Girardin, S.E., L.H. Travassos, M. Herve, D. Blanot, I.G. Boneca, D.J. Philpott, P.J. Sansonetti, and D. Mengin-Lecreulx. 2003. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. The Journal of Biological Chemistry 278: 41702–41708. · DOI · Paper page
- Kanneganti, T.D., M. Lamkanfi, and G. Nunez. 2007. Intracellular NOD-like receptors in host defense and disease. Immunity 27: 549–559. · DOI · Paper page
- Girardin, S.E., I.G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D.J. Philpott, and P.J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. The Journal of Biological Chemistry 278: 8869–8872. · DOI · Paper page
- Dziarski, R., and D. Gupta. 2005. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: A reevaluation. Infection and Immunity 73: 5212–5216. · DOI · Paper page
- Travassos, L.H., S.E. Girardin, D.J. Philpott, D. Blanot, M.A. Nahori, C. Werts, and I.G. Boneca. 2004. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Reports 5: 1000–1006. · DOI · Paper page
- Zahringer, U., B. Lindner, S. Inamura, H. Heine, and C. Alexander. 2008. TLR2—Promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213: 205–224. · DOI · Paper page
- Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nature Reviews. Immunology 4: 499–511. · DOI · Paper page
- Rittirsch, D., M.A. Flierl, and P.A. Ward. 2008. Harmful molecular mechanisms in sepsis. Nature Reviews. Immunology 8: 776–787. · DOI · Paper page
- Riedemann, N.C., R.F. Guo, and P.A. Ward. 2003. The enigma of sepsis. Journal of Clinical Investigation 112: 460–467. · DOI
- Mookherjee, N., H.L. Wilson, S. Doria, Y. Popowych, R. Falsafi, J.J. Yu, Y. Li, S. Veatch, F.M. Roche, K.L. Brown, F.S. Brinkman, K. Hokamp, A. Potter, L.A. Babiuk, P.J. Griebel, and R.E. Hancock. 2006. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. Journal of Leukocyte Biology 80: 1563–1574. · DOI · Paper page
- Nijnik, A., J. Pistolic, A. Wyatt, S. Tam, and R.E. Hancock. 2009. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. Journal of Immunology 183: 5788–5798. · DOI
- Heng, Z., Heiderscheidt, C.A., Joo, M., Gao, X., Knezevic, N., Mehta, D., and Sadikot, R.T. 2010. MyD88-dependent and -independent activation of TREM-1 via specific TLR ligands. Eur J Immunol 40(1) :162–171. · DOI
- Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443–451. · DOI · Paper page
- Yoshimura, A., E. Lien, R.R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. Journal of Immunology 163: 1–5. · DOI · Paper page
- Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C.J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. The Journal of Biological Chemistry 274: 17406–17409. · DOI · Paper page
- Carneiro, L.A., L.H. Travassos, and D.J. Philpott. 2004. Innate immune recognition of microbes through Nod1 and Nod2: Implications for disease. Microbes and Infection 6: 609–616. · DOI
- Lau, Y.E., A. Rozek, M.G. Scott, D.L. Goosney, D.J. Davidson, and R.E. Hancock. 2005. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infection and Immunity 73: 583–591. · DOI
- Mookherjee, N., D.N. Lippert, P. Hamill, R. Falsafi, A. Nijnik, J. Kindrachuk, J. Pistolic, J. Gardy, P. Miri, M. Naseer, L.J. Foster, and R.E. Hancock. 2009. Intracellular receptor for human host defense peptide LL-37 in monocytes. Journal of Immunology 183: 2688–2696. · DOI · Paper page
- Sandgren, S., A. Wittrup, F. Cheng, M. Jonsson, E. Eklund, S. Busch, and M. Belting. 2004. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. The Journal of Biological Chemistry 279: 17951–17956. · DOI · Paper page
Cited by
Immune modulation by multifaceted cationic host defense (antimicrobial) peptides
Hilchie, A. L., Wuerth, K., & Hancock, R. E. W. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1393 · Cited by 601
Self-citationOn the Role of NMR Spectroscopy for Characterization of Antimicrobial Peptides
Porcelli, F., Ramamoorthy, A., Barany, G., & Veglia, G. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-583-5_9 · Cited by 53
Metadata
- Authors
- Amatngalim, G. D., Nijnik, A., Hiemstra, P. S., & Hancock, R. E. W.
- Venue
- Inflammation
- Published
- 2010-09-02
- Volume
- 34
- Issue
- 5
- Pages
- 412-425
- ISSN
- 0360-3997
- 1573-2576
- Cited by
- 24
- References
- 7
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cathelicidin Peptide LL-37 Modulates TREM-1 Expression and Inflammatory Responses to Microbial Compounds. https://app.cochat.ai/papers/10.1007/s10753-010-9248-6
- The paper
- Amatngalim, G. D., Nijnik, A., Hiemstra, P. S., & Hancock, R. E. W. (2011). Cathelicidin Peptide LL-37 Modulates TREM-1 Expression and Inflammatory Responses to Microbial Compounds. Inflammation. https://doi.org/10.1007/s10753-010-9248-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.